As of 2025-12-17, the Relative Valuation of Atea Pharmaceuticals Inc (AVIR) is (36.84) USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.22 USD, the upside of Atea Pharmaceuticals Inc based on Relative Valuation is -1244.0%.
The range of the Relative Valuation is (36.09) - (37.97) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.6x - 20.2x | 19.2x |
| Forward P/E multiples | 19.2x - 20.7x | 20.0x |
| Fair Price | (36.09) - (37.97) | (36.84) |
| Upside | -1220.9% - -1279.3% | -1244.0% |
| Date | P/E |
| 2025-12-15 | -1.67 |
| 2025-12-12 | -1.67 |
| 2025-12-11 | -1.70 |
| 2025-12-10 | -1.68 |
| 2025-12-09 | -1.67 |
| 2025-12-08 | -1.70 |
| 2025-12-05 | -1.68 |
| 2025-12-04 | -1.64 |
| 2025-12-03 | -1.64 |
| 2025-12-02 | -1.59 |
| 2025-12-01 | -1.64 |
| 2025-11-28 | -1.65 |
| 2025-11-26 | -1.62 |
| 2025-11-25 | -1.61 |
| 2025-11-24 | -1.58 |
| 2025-11-21 | -1.58 |
| 2025-11-20 | -1.59 |
| 2025-11-19 | -1.67 |
| 2025-11-18 | -1.62 |
| 2025-11-17 | -1.60 |
| 2025-11-14 | -1.57 |
| 2025-11-13 | -1.63 |
| 2025-11-12 | -1.86 |
| 2025-11-11 | -1.80 |
| 2025-11-10 | -1.77 |
| 2025-11-07 | -1.74 |
| 2025-11-06 | -1.73 |
| 2025-11-05 | -1.72 |
| 2025-11-04 | -1.71 |
| 2025-11-03 | -1.73 |
| 2025-10-31 | -1.73 |
| 2025-10-30 | -1.74 |
| 2025-10-29 | -1.75 |
| 2025-10-28 | -1.71 |
| 2025-10-27 | -1.73 |
| 2025-10-24 | -1.71 |
| 2025-10-23 | -1.70 |
| 2025-10-22 | -1.74 |
| 2025-10-21 | -1.75 |
| 2025-10-20 | -1.71 |
| 2025-10-17 | -1.63 |
| 2025-10-16 | -1.66 |
| 2025-10-15 | -1.67 |
| 2025-10-14 | -1.67 |
| 2025-10-13 | -1.65 |
| 2025-10-10 | -1.67 |
| 2025-10-09 | -1.66 |
| 2025-10-08 | -1.65 |
| 2025-10-07 | -1.58 |
| 2025-10-06 | -1.55 |